Enter your terms above and click the 'Search' button.

Showing articles 0 to 11 of 11 Filter Applied: immune checkpoint inhibitors (Click to remove) Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016 A 48-Year-Old Woman with 6 Months of Vivid Visual Hallucinations Neurol 99:166-171, Kizza, J.,et al, 2022 Cranial Nerve Disorders Associated with Immune Checkpoint Inhibitors Neurol 96:e866-e875, Vogrig, A.,et al, 2021 Myasthenia Gravis Following Dabrafenib and Trametinib for Metastatic Melanoma Neurol 94:322-323, Zaloum, A.,et al, 2020 Sensory Ganglionopathy NEJM 383:1657-1662, Amato, A.A. & Ropper, A.H., 2020 Acute demyelinating polyneuropathy induced by nivolumab JNNP 89:435-437, Fukumoto, Y.,et al, 2018 Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer Neurol 91:e985-e994, Touat, M.,et al, 2018 Pembrolizumab-Induced Myasthenia Gravis Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018 Showing articles 0 to 11 of 11